Jane Street’s Aquestive Therapeutics AQST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.27M Buy
1,030,050
+517,830
+101% +$2.1M ﹤0.01% 3736
2025
Q4
$3.31M Buy
512,220
+438,267
+593% +$2.73M ﹤0.01% 3889
2025
Q3
$413K Buy
73,953
+8,335
+13% +$36K ﹤0.01% 8256
2025
Q2
$217K Buy
+65,618
New +$188K ﹤0.01% 8408
2025
Q1
Sell
-25,757
Closed -$91.7K 9367
2024
Q4
$91.7K Sell
25,757
-33,003
-56% -$152K ﹤0.01% 8791
2024
Q3
$293K Sell
58,760
-68,066
-54% -$265K ﹤0.01% 8073
2024
Q2
$330K Sell
126,826
-136,314
-52% -$455K ﹤0.01% 7661
2024
Q1
$1.12M Buy
263,140
+107,055
+69% +$356K ﹤0.01% 5211
2023
Q4
$315K Buy
+156,085
New +$276K ﹤0.01% 7525
2023
Q2
Sell
-23,430
Closed -$26.7K 8629
2023
Q1
$26.7K Buy
+23,430
New +$20.3K ﹤0.01% 8593
2021
Q3
Sell
-13,099
Closed -$52K 9876
2021
Q2
$52K Sell
13,099
-261
-2% -$1.04K ﹤0.01% 9494
2021
Q1
$69K Sell
13,360
-43,392
-76% -$231K ﹤0.01% 8766
2020
Q4
$304K Sell
56,752
-6,386
-10% -$38.3K ﹤0.01% 6396
2020
Q3
$306K Buy
63,138
+52,063
+470% +$340K ﹤0.01% 5853
2020
Q2
$54K Buy
+11,075
New +$51K ﹤0.01% 6854
2019
Q3
Sell
-31,597
Closed -$133K 5025
2019
Q2
$133K Buy
+31,597
New +$162K ﹤0.01% 4794

Other funds holding AQST

Jane Street's AQST Position: Q1 2026 in Review

Jane Street increased its Aquestive Therapeutics (AQST) stake by 101% in Q1 2026, buying an estimated $2.1M and bringing the position to 1,030,050 shares worth $4.27M. The position accounts for ﹤0.01% of the portfolio, ranked #3736.

Jane Street first reported a position in AQST in Q2 2019 and has held it in 16 quarters since. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Jane Street held 1,030,050 shares of Aquestive Therapeutics worth $4.27M as of Q1 2026.
  • Jane Street bought 517,830 Aquestive Therapeutics shares in Q1 2026, an estimated $2.1M.
  • Aquestive Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3736 holding.
  • Jane Street first reported a position in Aquestive Therapeutics in Q2 2019 and has held it in 16 quarters since.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.